Priority Healthcare Selected as a Provider of Ventavis
LAKE MARY, Fla., February 22, 2005 /PRNewswire-FirstCall/
-- Priority Healthcare Corporation announced that it has been selected
by CoTherix, Inc. to be a full-service specialty pharmacy provider of
Ventavis(TM) (iloprost) Inhalation Solution. The Food and Drug Administration
approved Ventavis(TM) on December 29, 2004 for the treatment of pulmonary
arterial hypertension (World Health Organization Group I) or PAH, in patients
with NYHA Class III or IV symptoms.
Nun who changed Catholic texts is subject of Oscar-nominated film
Thering suffers from diabetes and pulmonary hypertension and is largely
confined to a wheelchair. Still, she attended the Tribeca Film Festival last
spring _ where the film won for Best Documentary Short and she met Robert De
Niro, among others _ and earlier this month she flew to Los Angeles to
attend the Oscar nominees' luncheon at the Beverly Wilshire Hotel.
Pulmonary
Hypertension - A Patient's Survival Guide The premiere information resource
for people dealing with PH -- they have ARRIVED and are ready to
ship!!!
The author, a PH patient herself,
knows what it is like to live with the disease. She talked to many
other patients, doctors, and researchers while writing the Survival
Guide. Dr. Ronald J. Oudiz and a team of physicians with a deep
knowledge of PH edited the book for accuracy.
New edition contains a chart
of 15 drugs used to treat PH; results of recent
clinical trials;
in-depth discussion of PH secondary to other diseases
or conditions;
a new chapter on what to eat if you have PH; and much, much more!
Over the past seven years, the Stibbses and their band of volunteers have
raised more than $850,000 for PH research. In 2005 they are raising the bar
even higher with a goal to achieve the $1 million mark. It is undoubtedly a
difficult challenge, but one that they are convinced they will achieve.
People with pulmonary hypertension
may soon have a new medication at their disposal, if the government gives
the drug its endorsement. The manufacturer of the experimental oral medication
says it plans to seek approval from the Food and Drug Administration (FDA)
to market sitaxsentan, also known by its marketing brand, ThelinR.
The annual awareness conference
of the Irish Raynaud's and Scleroderma Society will be held on Saturday
April 23 in the Stillorgan Park Hotel, Co. Dublin from 10 am to 4pm.
Presentations will be given
by top professionals on topics such as new ways of managing Raynaud's,
dental protection, nutrition, pulmonary hypertension and caring for digital
ulcers.
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
